We applaud Varughese et al. on their Grand Round (JRSM, November 2006) highlighting the caveats to be exercised from a practical perspective, when managing patients with hypothyroidism on levothyroxine replacement. 1 Their comprehensive discussion serves to remind clinicians of the intricacies in the management of hypothyroidism and the potential cautions to be remembered in such circumstances.
In this context it would be worth noting that tablet formulation of levothyroxine has also been demonstrated to be absorbed less well than powdered levothyroxine, 2 and interestingly the degradation of tablet based formulations of levothyroxine with preservative have been reported to occur faster in contrast to oral liquid formulation of levothyroxine 25 mg/mL compounded from crushed tablets. 3 The controversial issues in the management of thyroid disease are crucial for both primary and secondary care clinicians. 4 Indeed, in some situations the timing of treatment in patients with hyperthyroidism is also equally important and should be explored in detail. 5 As an illustrative example, the same authors had reported on a patient with end stage renal disease on haemodialysis who developed hyperthyroidism. 5 Despite titrating the dose of treatment, carbimazole therapy in the setting of haemodialysis had been suggested to be less efficacious due to the fact that the conversion of carbimazole to its active form (methimazole) is inhibited in an acidic environment; it is of note that methimazole is not protein bound and is therefore dialysed. 5 Propylthiouracil, another antithyroid agent, is protein bound and would not get dialysed in such patients. 5 A high index of suspicion is required in such clinical scenarios and as Varughese et al. emphasize in their Grand Round, the possibility of other causes should be further explored before patient compliance is doubted.
Competing interests None declared. Training tomorrow's surgeons Jackson and Gibbin 1 point out that one of the fundamental problems faced by today's surgical trainees is decreased operative exposure. This is a result of a combination of reduced working hours due to the European Working Time Directive, and shortened surgical training. In addition, there has been much debate over the medico-legal and ethical issues regarding consent, where trainees practice on real patients under the supervision of surgical tutors. 2, 3 The traditional assessment of direct observation of trainee performance is often influenced by subjectivity, since different trainers have different expectations, and the use of a logbook only demonstrates individual trainee operative exposure and not competency. The accuracy of these logbooks are also often questionable as they rely heavily on self-assessment, and hence tend to lack reliability and validity. 4 We therefore agree with the authors that we have much to learn from the aviation industry, especially regarding the use of virtual reality simulators. Virtual reality simulators allow automated objective measurements and assessment of surgical skills, which were not previously possible. It also allows new surgical trainees to be trained in their own time without endangering patient lives, and for some simulators, the predictive validity of skills transfer to real operations has been proven.
Although this type of training is still in its infancy, we can anticipate that virtual reality simulators will be a great asset to the surgical training curriculum, both as means of training, as well as an assessment tool. 
